title: Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice.
abstract: Infection of the mammary gland, in addition to causing animal distress, is a major economic burden of the dairy industry. Staphylococcus aureus is the major contagious mastitis pathogen, accounting for approximately 15-30% of infections, and has proved difficult to control using standard management practices. As a first step toward enhancing mastitis resistance of dairy animals, we report the generation of transgenic mice that secrete a potent anti-staphylococcal protein into milk. The protein, lysostaphin, is a peptidoglycan hydrolase normally produced by Staphylococcus simulans. When the native form is secreted by transfected eukaryotic cells it becomes glycosylated and inactive. However, removal of two glycosylation motifs through engineering asparagine to glutamine codon substitutions enables secretion of Gln(125,232)-lysostaphin, a bioactive variant. Three lines of transgenic mice, in which the 5'-flanking region of the ovine beta-lactoglobulin gene directed the secretion of Gln(125,232)-lysostaphin into milk, exhibit substantial resistance to an intramammary challenge of 104 colony-forming units (c.f.u.) of S. aureus, with the highest expressing line being completely resistant. Milk protein content and profiles of transgenic and nontransgenic mice are similar. These results clearly demonstrate the potential of genetic engineering to combat the most prevalent disease of dairy cattle.
authors.affiliation: Department of Animal Sciences, University of Vermont, Burlington, VT 05405, USA. dkerr@zoo.uvm.edu
authors.forename: D E
authors.initials: DE
authors.lastname: Kerr
authors.forename: K
authors.initials: K
authors.lastname: Plaut
authors.forename: A J
authors.initials: AJ
authors.lastname: Bramley
authors.forename: C M
authors.initials: CM
authors.lastname: Williamson
authors.forename: A J
authors.initials: AJ
authors.lastname: Lax
authors.forename: K
authors.initials: K
authors.lastname: Moore
authors.forename: K D
authors.initials: KD
authors.lastname: Wells
authors.forename: R J
authors.initials: RJ
authors.lastname: Wall
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D001216:Asparagine; D002417:Cattle; D005260:Female; D005818:Genetic Engineering; D005973:Glutamine; D007774:Lactation; D008239:Lysine; D008248:Lysostaphin / Q000096:biosynthesis* / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000502:physiology*; D008414:Mastitis, Bovine / Q000517:prevention & control; D051379:Mice; D008822:Mice, Transgenic; D008892:Milk / Q000378:metabolism / Q000502:physiology*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013210:Staphylococcus / Q000235:genetics*
chemical_list: D011994:Recombinant Proteins; D005973:Glutamine; D001216:Asparagine; D008248:Lysostaphin; D008239:Lysine